Olivieri controlled substances therapeutic
research program established; participation. 1. The Antonio G. Olivieri
controlled substances therapeutic research program is hereby established
in the department of health. The commissioner shall promulgate rules and
regulations necessary for the proper administration of the controlled
substances therapeutic research act. In such promulgation, the
commissioner shall take into consideration those pertinent rules and
regulations promulgated by the drug enforcement administration, food and
drug administration and the national institute on drug abuse.
2. Participation in the Antonio G. Olivieri controlled substances
therapeutic research program shall be limited to cancer patients,
glaucoma patients and patients afflicted with other diseases as such
diseases are approved by the commissioner. Such patient shall be
certified by a physician to and approved by a patient qualification
review board or committee in the manner provided by this article.
Physician certification and board or committee approval shall be limited
to such patients who are involved in a life-threatening or
sense-threatening situation. Patients seeking participation in such
program may seek the advice and shall be entitled to be advised by
appropriate medical personnel concerning the medical efficacy of
treatment with conventional controlled substances.
3. The commissioner, on behalf of the department, shall apply to the
food and drug administration for an investigational new drug permit
within ninety days after the effective date of this section.